Market Cap 58.98B
Revenue (ttm) 14.20B
Net Income (ttm) 4.41B
EPS (ttm) N/A
PE Ratio 14.40
Forward PE 18.10
Profit Margin 31.07%
Debt to Equity Ratio 0.07
Volume 868,200
Avg Vol 965,940
Day's Range N/A - N/A
Shares Out 105.99M
Stochastic %K 8%
Beta 0.35
Analysts Strong Sell
Price Target $729.50

Company Profile

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to...

Industry: Biotechnology
Sector: Healthcare
Phone: 914 847 7000
Address:
777 Old Saw Mill River Road, Tarrytown, United States
DrAzevedo
DrAzevedo Sep. 11 at 9:13 PM
$REGN Regeneron settles patent dispute with Sandoz over Eylea biosimilar- looks positive right?
0 · Reply
neanderthal_investments
neanderthal_investments Sep. 11 at 9:03 PM
$REGN this will be a very good investment here
0 · Reply
SniperPro
SniperPro Sep. 11 at 5:48 PM
$TSLA $BABA $LXRX $REGN $UNH EVERYTHING IS SO FREAKING GREEN, I WONDER WHY? # F THAT! LET'S KEEP IT GREEN BABY... LFG AND ENJOY THE RIDEEEE!!! ...
0 · Reply
Iwannagofast1
Iwannagofast1 Sep. 11 at 4:07 PM
$REGN When is the $20 swing???? ….or the $5 range for days ???? Mr MM spin the wheel l, so we can win big dumb prizes from you. You’re a turd buddy, and your wife runs the show !! Bet you sleep on the couch, and you have a micro peen. See ya in 2030 at $1200-1300+ ya goof
0 · Reply
droptopfibonacci
droptopfibonacci Sep. 11 at 2:00 PM
$REGN in @ 563.10 for a swing
0 · Reply
Iwannagofast1
Iwannagofast1 Sep. 11 at 1:57 PM
$REGN Hey where is our five dollar range market maker? This is unacceptable…. Also where is village idiot @Johny34211? Is he busy pre-logging the 22 bearish comments for whenever he shows up? What a moron.
0 · Reply
Iwannagofast1
Iwannagofast1 Sep. 11 at 2:39 AM
$REGN are any of you impressed with the absolute strength of this market maker and the powers that he has? I’m not. He’s a clown🤡🤡🤡🤡🤡🤡🤡 we’re so glad that you can keep a stock within four and five dollars for the entire day. Put it on your resume buddy. Maybe you can get your first girlfriend with this power. @Johny34211 is your #1 fan though I’m sure lololololol
0 · Reply
Iwannagofast1
Iwannagofast1 Sep. 11 at 2:32 AM
$REGN Hi REGN fam, I was busy golfing most of my day. I loved the range in the chart today. MM you do a very good job of range binding a $555 stock, it’s perfect for a guy w no balls like yourself. See you in 2029-2030.
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Sep. 10 at 8:00 PM
$REGN what a close...
0 · Reply
gargoyl
gargoyl Sep. 10 at 5:25 PM
0 · Reply
Latest News on REGN
Regeneron: EYLEA's Decline Is Masking A Deep Value Opportunity

Aug 11, 2025, 11:36 AM EDT - 4 weeks ago

Regeneron: EYLEA's Decline Is Masking A Deep Value Opportunity


Regeneron: Rapidly Decreasing Importance Of Eylea

Aug 1, 2025, 4:05 PM EDT - 5 weeks ago

Regeneron: Rapidly Decreasing Importance Of Eylea


US FDA approves Regeneron's blood cancer therapy

Jul 2, 2025, 11:11 AM EDT - 2 months ago

US FDA approves Regeneron's blood cancer therapy


Regeneron Pharma Shares Rise Over 3% After Key Signal

Jun 10, 2025, 7:48 AM EDT - 3 months ago

Regeneron Pharma Shares Rise Over 3% After Key Signal


Why Regeneron Is Falling And Why You Should Avoid It

Jun 4, 2025, 11:19 AM EDT - 3 months ago

Why Regeneron Is Falling And Why You Should Avoid It


DrAzevedo
DrAzevedo Sep. 11 at 9:13 PM
$REGN Regeneron settles patent dispute with Sandoz over Eylea biosimilar- looks positive right?
0 · Reply
neanderthal_investments
neanderthal_investments Sep. 11 at 9:03 PM
$REGN this will be a very good investment here
0 · Reply
SniperPro
SniperPro Sep. 11 at 5:48 PM
$TSLA $BABA $LXRX $REGN $UNH EVERYTHING IS SO FREAKING GREEN, I WONDER WHY? # F THAT! LET'S KEEP IT GREEN BABY... LFG AND ENJOY THE RIDEEEE!!! ...
0 · Reply
Iwannagofast1
Iwannagofast1 Sep. 11 at 4:07 PM
$REGN When is the $20 swing???? ….or the $5 range for days ???? Mr MM spin the wheel l, so we can win big dumb prizes from you. You’re a turd buddy, and your wife runs the show !! Bet you sleep on the couch, and you have a micro peen. See ya in 2030 at $1200-1300+ ya goof
0 · Reply
droptopfibonacci
droptopfibonacci Sep. 11 at 2:00 PM
$REGN in @ 563.10 for a swing
0 · Reply
Iwannagofast1
Iwannagofast1 Sep. 11 at 1:57 PM
$REGN Hey where is our five dollar range market maker? This is unacceptable…. Also where is village idiot @Johny34211? Is he busy pre-logging the 22 bearish comments for whenever he shows up? What a moron.
0 · Reply
Iwannagofast1
Iwannagofast1 Sep. 11 at 2:39 AM
$REGN are any of you impressed with the absolute strength of this market maker and the powers that he has? I’m not. He’s a clown🤡🤡🤡🤡🤡🤡🤡 we’re so glad that you can keep a stock within four and five dollars for the entire day. Put it on your resume buddy. Maybe you can get your first girlfriend with this power. @Johny34211 is your #1 fan though I’m sure lololololol
0 · Reply
Iwannagofast1
Iwannagofast1 Sep. 11 at 2:32 AM
$REGN Hi REGN fam, I was busy golfing most of my day. I loved the range in the chart today. MM you do a very good job of range binding a $555 stock, it’s perfect for a guy w no balls like yourself. See you in 2029-2030.
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Sep. 10 at 8:00 PM
$REGN what a close...
0 · Reply
gargoyl
gargoyl Sep. 10 at 5:25 PM
0 · Reply
kenbkb
kenbkb Sep. 10 at 3:36 PM
$REGN Please, please no more good news on Phase 3 trials <insert sarcasm>!!
0 · Reply
highnihilism
highnihilism Sep. 10 at 3:15 PM
$REGN Regeneron Q2 EPS $12.89, Sepio raised stake 33%. Expanding U.S. manufacturing through a $3B FujiFilm deal & buying 23andMe for $256M in genetic data. Pharmaceuticals meet data mining. #ETSY Etsy’s platform engagement & merchant growth are reinforcing the $72 level. Consumer-spending resilience (whimsigoth, fetish fashion, nostalgia, handmade crafts, domestic charm, heritage demand). #SG Sweetgreen’s luxury athleisure lifestyle setting: bright & clean interior, crisp greens, bright wooden textures (post-class vibe) is reinforcing the $18 level. Where energized femininity resonates. #XHB Homebuilder demand trends & housing supply dynamics are reinforcing the $120 level. Fed rate-cut speculation & “golden cross” approaching. #BTC Bitcoin’s on-chain metrics & institutional flows are propping up the $114,000 level. Fed rate-cut speculation & “liquidity expansion.”
1 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Sep. 10 at 2:14 PM
$REGN I don't think DJT and LEN are good golfing buddies anymore...
1 · Reply
Quantumup
Quantumup Sep. 10 at 12:37 PM
Oppenheimer⬆️the PT on $TYRA to $36 from $30 reiterated at an Outperform and said, we hosted $TYRA for meetings in Boston on Monday. [ $REGN $PFE $RHHBY $MRK BMY ] In each meeting, management made the case for why dabogratinib's combined market opportunity exceeds $10B. That's nearly Regeneron-esque revenues. Despite that, investors still complain that all the major catalysts aren't until 2026. Fine. But don't expect to find shares at this price -with a sub-$500M enterprise value-next year. This is one of the most de-risked stories we've ever covered because the roles that FGFR3 plays in both cancer and bone growth are so well-validated. What we hadn't truly appreciated was the sheer size of the market. We are revamping our model to increase peak sales in both NMIBC and Achondroplasia, while still feeling that our numbers leave room for upside. Reiterate Outperform; PT to $36.
0 · Reply
SPYmyQQQ
SPYmyQQQ Sep. 10 at 12:01 AM
🌙 EOD Recap ✅ $REGN 🗓️ Sep 9, 2025 (8pm ET) 💵 Our Entry: $558.2600 🎯 Target: $576.8501 (+3.33%)
0 · Reply
SPYmyQQQ
SPYmyQQQ Sep. 9 at 7:34 PM
🚨 New Signal ✅ 🏛️ $REGN 🗓️ Sep 9, 2025 💵 Entry: $558.26 🎯 Suggested Target: $576.85 (+3.33%) (Optional) $SPY my $QQQ
0 · Reply
Iwannagofast1
Iwannagofast1 Sep. 9 at 5:50 PM
$REGN I think the three dollar range is cute. I love it.
0 · Reply
Iwannagofast1
Iwannagofast1 Sep. 9 at 4:30 PM
$REGN Hey MM I’m here for all the games you got until 2029-2030. So keep it wherever you want. I am going in with another 75K every $50 down and I have 10.4 million reasons to throw more money here. Make me wealthier buddy, but until then, keep playing w your pud and REGN like they tell ya to little boy. 🫡
1 · Reply
dogDazeSummer
dogDazeSummer Sep. 9 at 1:06 PM
$IFRX HCW- Con’t CSU: “CSU represents a significant commercial opportunity. In the U.S., urticaria prevalence is estimated to be 0.5-1% of the total population (approximately 1 to 3 million individuals). Estimates place the CSU market value at approximately $2 billion in the U.S., and a $7-8 billion market for the indication worldwide. Unfortunately, available therapies are limited and only provide symptomatic relief. Current options include: 1) antihistamines, 2) leukotriene receptor antagonists, 3) omalizumab (brand name XOLAIR), $RHHBY 4) dupilumab (brand name DUPIXENT) $SNY and $REGN https://www.barrons.com/articles/regeneron-blockbuster-dupixent-rival-ef230b36
0 · Reply
Iwannagofast1
Iwannagofast1 Sep. 9 at 11:59 AM
$REGN @Johny 34211 is alive and well in case you were wondering. He replied yesterday even though he said he’s done posting for awhile (48hrs)! I’ll post for him today…. “You have all been warned that this stock will deplete your savings accts and your 401Ks. This will touch $300 soon and don’t tell me later you haven’t been warned, this is Shiteron and it’s coming for you !!! “ lolololololol
0 · Reply
pnvoss
pnvoss Sep. 9 at 10:34 AM
$SPY think I'll buy $LULU and $REGN to balance out and diversify by holding of $MARA long-term swings in those
1 · Reply
pnvoss
pnvoss Sep. 9 at 10:25 AM
$SPY $LULU looks decent for a long-term swing so does $REGN
0 · Reply